Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Tóm tắt
The incidence of gastric cancer continues to decrease globally, approaching levels that in some populations could define it as a rare disease. To explore this on a wider scale, we predict its future burden in 34 countries with long-standing population-based data.
Data on gastric cancer incidence by year of diagnosis, sex and age were extracted for 92 cancer registries in 34 countries included in
Overall gastric cancer incidence rates are predicted to continue falling in the future in the majority of countries, including high-incidence countries such as Japan (ASR 36 in 2010 vs ASR 30 in 2035) but also low-incidence countries such as Australia (ASR 5.1 in 2010 vs ASR 4.6 in 2035). A total of 16 countries are predicted to fall below the rare disease threshold (defined as 6 per 100 000 person-years) by 2035, while the number of newly diagnosed cases remains high and is predicted to continue growing. In contrast, incidence increases were seen in younger age groups (below age 50 years) in both low-incidence and high-incidence populations.
While gastric cancer is predicted to become a rare disease in a growing number of countries, incidence levels remain high in some regions, and increasing risks have been observed in younger generations. The predicted growing number of new cases highlights that gastric cancer remains a major challenge to public health on a global scale.
Từ khóa
Tài liệu tham khảo
Hamashima, 2018, Guideline development group for gastric cancer screening G. update version of the Japanese guidelines for gastric cancer screening, Jpn J Clin Oncol, 48, 673, 10.1093/jjco/hyy077
Jun, 2017, Effectiveness of the Korean National cancer screening program in reducing gastric cancer mortality, Gastroenterology, 152, 1319, 10.1053/j.gastro.2017.01.029
Ferlay J , Colombet M , Bray F . Cancer incidence in five continents, CI5plus: IARC CancerBase No. 9. Lyon, France: International Agency for Research on Cancer, 2018.
World Population Prospects. . The 2017 revision. New York: United Nations, Department of Economics and Social Affairs, Population Division, 2017.
Doll R , Payne P , Waterhouse J . Cancer incidence in five continents: a technical report. Berlin 1966.
Howson, 1986, The decline in gastric cancer: epidemiology of an unplanned triumph, Epidemiol Rev, 8, 1, 10.1093/oxfordjournals.epirev.a036288
Collaborators GBDSC . The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2019.
Anderson, 2018, The changing face of Noncardia gastric cancer incidence among US non-Hispanic whites, J Natl Cancer Inst, 110, 608, 10.1093/jnci/djx262
Diet, Nutrition, Physical activity, and Stomach Cancer . Continuous update project report. world cancer research fund / American Institute for cancer research 2016.
Praud, 2018, Cigarette smoking and gastric cancer in the stomach cancer pooling (stop) project, Eur J Cancer Prev, 27, 124, 10.1097/CEJ.0000000000000290
Ford, 2014, Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials, BMJ, 348, 10.1136/bmj.g3174
Francois, 2011, The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin, BMC Gastroenterol, 11, 10.1186/1471-230X-11-37
Holster, 2012, The impact of Helicobacter pylori on atopic disorders in childhood, Helicobacter, 17, 232, 10.1111/j.1523-5378.2012.00934.x
Choi, 2018, Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial, Gastrointest Endosc, 88, 475, 10.1016/j.gie.2018.05.009
Leja, 2017, Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study, BMJ Open, 7, 10.1136/bmjopen-2017-016999
Lee, 2011, Gastric cancer screening in Korea: report on the National cancer screening program in 2008, Cancer Res Treat, 43, 83, 10.4143/crt.2011.43.2.83
Nakamura, 1977, An evaluation of gastric cancer screening program in Hisayana, Japan, Gastroenterol Jpn, 12, 427, 10.1007/BF02781334
Lee, 2015, Gastric cancer screening uptake trends in Korea: results for the National cancer screening program from 2002 to 2011: a prospective cross-sectional study, Medicine, 94, 10.1097/MD.0000000000000533
Jung, 2019, Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016, Cancer Res Treat, 51, 417, 10.4143/crt.2019.138
Asaka, 2014, Strategies for eliminating death from gastric cancer in Japan, Proc Jpn Acad Ser B, 90, 251, 10.2183/pjab.90.251
Bray, 2016, Cancer patterns, trends and projections in Latin America and the Caribbean: a global context, Salud Publica Mex, 58, 104, 10.21149/spm.v58i2.7779
Joliat, 2015, Future development of gastrointestinal cancer incidence and mortality rates in Switzerland: a tumour registry- and population-based projection up to 2030, Swiss Med Wkly, 145, w14188
Simms, 2019, Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study, Lancet Oncol, 20, 394, 10.1016/S1470-2045(18)30836-2
Engholm G , Ferlay J , Christensen N , et al . NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 8.1 (28.06.2018). Association of the Nordic cancer registries. Danish cancer Society 2018.
Cancer Data in Australia . Australian cancer incidence and mortality (ACIM) books: stomach cancer. Canberra: Australian Institute of Health and Welfare (AIHW), 2018.